Results 251 to 260 of about 363,022 (358)

Hematopoietic stem cell heterogeneity and age-related platelet bias: implications for bone marrow transplantation and blood disorders. [PDF]

Stem Cell Res Ther
Chen Y, Shentu J, Lou H, Xia Y, Jiang Y, Duan S.   +5 more
europepmc   +1 more source

Cell migration, chimerism, and graft acceptance: with particular reference to the liver [PDF]

, 1996
Demetris, AJ, Murase, N, Ricordi, C, Starzl, TE, Trucco, M   +4 more
core  

Cell migration, chimerism, and graft acceptance [PDF]

, 1992
A.J Demetris, Armstrong, Arnaud-Battandier, Billingham, Billingham, C Ricordi, Calne, Cranston, Davies, Demetris, Demetris, Faustman, Fung, Gjertson, Hart, Ildstad, Iwaki, Kashiwagi, Kashiwagi, Lechler, M Trucco, Markus, Medawar, Monaco, Murase, Murase, Murase, Murase, N Murase, Porter, Prop, Ramsey, Ricordi, S Ildstad, Selby, Singh, Slavin, Starzl, Starzl, Starzl, Steinman, Steinmuller, T.E Starzl, Talmage, Webb, Wilson, Woodruff, Woodruff   +47 more
core   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML. [PDF]

EJHaem
Mitsuyoshi T, Arai Y, Kondo T, Kawata T, Hirabayashi S, Tanaka M, Mori Y, Doki N, Nishida T, Kotani T, Ogata M, Tabayashi T, Eto T, Sawa M, Imada K, Kanda J, Ichinohe T, Atsuta Y, Yanada M.   +18 more
europepmc   +1 more source

Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study

American Journal of Hematology, EarlyView.
Zhenbin Wei, Rongrong Liu, Lingling Shi, Qiaochuan Li, Lianjin Liu, Baoshi Zheng, Chunjie Qin, Hong Chen, Guyun Wang, Meiqing Wu, Gaohui Yang, Ruolin Li, Zhaoping Gan, Qi Zhou, Jing Fan, Xuemei Zhou, Yinghua Chen, Zhiyu Zeng, Zhongming Zhang, Yongrong Lai   +19 more
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors. [PDF]

Bone Marrow Transplant
Galeano S, Bonfim C, Karduss A, Jaimovich G, Gómez-De León A, Bettarello G, Simione A, Correa C, Baldomero H, Neumann D, Basquiera AL, Berro M, Remaggi G, Amaru A, Barroso F, Seber A, Barriga F, Palma J, Puga B, Sánchez M, Herrera JM, Hernández C, Gómez-Almaguer D, Gaytán Morales F, Ruiz-Argüelles GJ, Mendoza N, Benítez ML, Wong A, Pagés C, Hernández M, Niederwieser D, Rondelli D, Frutos C.   +32 more
europepmc   +1 more source

The clinical implication of cell migration in liver transplantation [PDF]

, 1996
Starzl, TE
core  

Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioning

British Journal of Clinical Pharmacology, EarlyView.
Aims In haematopoietic cell transplantation (HCT), neutropenia resulting from myelosuppression is an expected endpoint following busulfan‐based conditioning. However, if prolonged, neutropenia can lead to complications like serious infection and death.
Beth Apsel Winger, Joseph W. Polli, Janel Long‐Boyle, Andrew Weber, Jordan Brooks, Jaimit Parikh, Valeriu Damian   +6 more
wiley   +1 more source